Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05682144 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 1 of 2 sitesv12
  2. Enrollment target: 2 to 11v11 Show 5 more changesShow less
    • Primary completion date: Jun 1, 2025 to Jun 1, 2029
    • Study completion date: Jun 1, 2039 to Jun 1, 2044
    • Eligibility criteria revised
    • Study arms: 1 to 2
    • Study description shortened, about 1 word
  3. Re-verified, no change to tracked fieldsv10
  4. Site contacts updated at 1 of 2 sitesv9
  5. Re-verified, no change to tracked fieldsv8
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 1 to 2v7
  2. Primary completion date: Apr 1, 2024 to Jun 1, 2025
    • Study completion date: Oct 1, 2024 to Jun 1, 2039
    v6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 15, 2023 to Apr 12, 2023
    • Site details revised
    v5
  4. Secondary endpoints: details revised at 1 of 6 entriesv4
  5. Secondary endpoints: details revised at 1 of 6 entriesv3
  6. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A first-in-human study using ISP-001 in patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.
Trial Details
NCT Number NCT05682144
Lead Sponsor Immusoft of CA, Inc.
Conditions
(from sponsor)		 Mucopolysaccharidosis IH/S, Mucopolysaccharidosis IS
Related terms Mucopolysaccharidosis I
Enrollment 11 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov